Laman UtamaVBIVQ • OTCMKTS
add
VBI Vaccines Inc
Tutup sebelumnya
$0.00050
Julat hari
$0.00050 - $0.00060
Julat tahun
$0.00020 - $0.051
Permodalan pasaran
7.17K USD
Bilangan Purata
56.23K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
OTCMKTS
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.21J | 150.31% |
Perbelanjaan pengendalian | 10.24J | -37.68% |
Pendapatan bersih | -17.90J | 35.50% |
Margin untung bersih | -1.47K | 74.23% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -11.26J | 40.75% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 12.60J | -68.82% |
Jumlah aset | 75.44J | -41.27% |
Jumlah liabiliti | 80.91J | -3.03% |
Jumlah ekuiti | -5.47J | — |
Syer tertunggak | 28.68J | — |
Harga kepada buku | -0.00 | — |
Pulangan pada aset | -36.18% | — |
Pulangan pada modal | -55.53% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -17.90J | 35.50% |
Tunai daripada operasi | -11.77J | 45.65% |
Tunai daripada pelaburan | -151.00K | 71.72% |
Tunai daripada pembiayaan | 843.00K | — |
Perubahan bersih dalam tunai | -11.09J | 50.13% |
Aliran tunai bebas | -4.40J | 70.09% |
Perihal
Variation Biotechnologies Inc., also known as VBI Vaccines Inc., is a biopharmaceutical company, headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Ontario, Canada, and a research and manufacturing site in Rehovot, Israel. Its Ottawa facility has approximately thirty researchers working with National Research Council of Canada to produce a COVID-19 vaccine—VBI-2902. In August VBI received CA$56 million from the Government of Canada to prepare its vaccine for clinical trials by the end of 2020. The company's CEO, Jeff Baxter, said that VBI-2902 is cheaper to produce than other vaccines. Wikipedia
Diasaskan
1965
Tapak web
Pekerja
135
